Expression of soluble interleukin-2 receptor and tissu estrogen receptor in patients with thyroid papillary carcinoma
Zeng Chijia, Duan Zhaohui, Jianhua Huang
Abstract
Zeng Chijia, Duan Zhaohui, Jianhua Huang
Abstract
OBJECTIVE:To study the expression of Soluble interleukin-2 receptor (SIL-2R) and Estrogen receptor(ER) in patients with thyroid carcinoma. METHODS: Expresion of ER were detected by immunohistochemistry SP method in 50 cases of thyroid papillary carcinoma and 20 cases of follicular carcinoma and 10 cases marrow shape carcinoma.RESULTS: The SIL-2R level in patients with thyroid carcinoma were (118.20±43.50) pmol/L obviously higher than thyroid node group (50.28±12.28) pmol/L and normal control group(49.2±13.32 ) pmol/L; Serum SIL-2R level in 20 day after operation was drop to normal; There was no significant difference between thyroid carcinoma and pathological; The expression positive rate of ER in papilla shape were 67.3% obviously higher than that thyroid carcinoma of follicle (40.0%) and normal control (8.0%);The expression positive rate in primary thyroid carcinoma were 74.2% significantly highter than that in cases of recurrence (20.0%); The expression positive rate in cases without lymph node metastasis were 68.5%,highter than that in cases with lymph metastasis (46.6%). CONCLUSIONS: These suggest that there is clinical significance for distinguishing thyroid benign disease from malignant,evaluating curative effect and prognosis by measuring expression SIL-2R and ER.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the expression of Soluble interleukin-2 receptor (SIL-2R) and Estrogen receptor(ER) in patients with thyroid carcinoma. METHODS: Expresion of ER were detected by immunohistochemistry SP method in 50 cases of thyroid papillary carcinoma and 20 cases of follicular carcinoma and 10 cases marrow shape carcinoma.RESULTS: The SIL-2R level in patients with thyroid carcinoma were (118.20±43.50) pmol/L obviously higher than thyroid node group (50.28±12.28) pmol/L and normal control group(49.2±13.32 ) pmol/L; Serum SIL-2R level in 20 day after operation was drop to normal; There was no significant difference between thyroid carcinoma and pathological; The expression positive rate of ER in papilla shape were 67.3% obviously higher than that thyroid carcinoma of follicle (40.0%) and normal control (8.0%);The expression positive rate in primary thyroid carcinoma were 74.2% significantly highter than that in cases of recurrence (20.0%); The expression positive rate in cases without lymph node metastasis were 68.5%,highter than that in cases with lymph metastasis (46.6%). CONCLUSIONS: These suggest that there is clinical significance for distinguishing thyroid benign disease from malignant,evaluating curative effect and prognosis by measuring expression SIL-2R and ER.
Key concepts: Thyroid carcinoma, Medicine, Estrogen receptor, Thyroid, Immunohistochemistry, Carcinoma, Internal medicine, Pathological